| PACKAGING TYPE: | 10x15 Alu-alu (10 Strips In 1 Box) |
| COMPOSITION: | Dapagliflozin 5mg + Metformin (er) Hcl 1000mg |
| FORMULATION: | Tablet |
| Description: | FOXISAFE-M 5/1000 Tablet is a combination antidiabetic medication containing Dapagliflozin 5 mg and Metformin Hydrochloride (Extended Release) 1000 mg. It is used for the management of type 2 diabetes mellitus to improve glycemic control. Dapagliflozin, an SGLT2 inhibitor, promotes glucose excretion via urine, while Metformin reduces hepatic glucose production and enhances insulin sensitivity. This combination offers effective blood sugar control and supports long-term metabolic and cardiovascular health in adult patients. |
| Side Effects: | Some individuals may experience: Increased urination Nausea, diarrhea, or abdominal discomfort Urinary tract or genital infections Dizziness or dehydration Serious side effects (rare) include lactic acidosis or diabetic ketoacidosis—seek immediate medical attention if symptoms occur. |
| How to Use: | Take the tablet as prescribed by a healthcare professional. Swallow whole; do not crush or chew (ER formulation). Take with meals to minimize gastrointestinal discomfort. Take at the same time every day. Follow a healthy diet and exercise plan. |
| Precaution: | Use cautiously in patients with kidney or liver impairment. Avoid excessive alcohol due to risk of lactic acidosis. Monitor blood sugar levels regularly. Inform your doctor about other medications. Not recommended during pregnancy or breastfeeding without medical advice. Maintain proper hydration to prevent dehydration. |
| Product Benefits: | Provides dual mechanism for better glycemic control. Helps reduce HbA1c levels effectively. Promotes urinary glucose excretion. Improves insulin sensitivity and glucose metabolism. Supports weight management and cardiovascular health. |
Frequently Asked Questions
It is used to manage type 2 diabetes mellitus with enhanced blood sugar control.
The combination provides dual action—promoting glucose excretion and improving insulin sensitivity.
Yes, mild gastrointestinal issues may occur, primarily due to Metformin ER.












